New Genetron Holding Limited agreed to acquire Genetron Holdings Limited (NasdaqGM:GTH) for $130 million on October 11, 2023. The Merger, which is currently expected to close during the first quarter of 2024, is subject to customary closing conditions, including, among others, that the Merger Agreement shall be authorized and approved by an affirmative vote of shareholders representing at least two-thirds of the Shares present and voting in person or by proxy at an extraordinary general meeting of the Company?s shareholders, that the aggregate amount of Dissenting Shares shall be less than 15% of the total outstanding Shares immediately prior to the Effective Time, and certain regulatory approvals, including the ODI Approval (as defined in the Merger Agreement) for certain Consortium members in China.

Kroll, LLC (operating through its Duff & Phelps Opinions Practice) is serving as the financial advisor to the Special Committee, and Li He, Xuelin (Steve) Wang of Davis Polk & Wardwell LLP is serving as U.S. legal counsel to the Special Committee and the Company. Peter X Huang of Skadden, Arps, Slate, Meagher & Flom LLP is serving as U.S. legal counsel to the Consortium, and King & Wood Mallesons is serving as PRC legal counsel to the Consortium. Latham & Watkins LLP is serving as U.S. legal counsel to CICC. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is serving as U.S. legal counsel to Wuxi Guolian, and Jincheng Tongda & Neal is serving as PRC legal counsel to Wuxi Guolian. Llinks Law Offices is serving as PRC legal counsel to Wuxi Huihongyingkang Investment Partnership (Limited Partnership). Certain legal matters with respect to the Cayman Islands law are advised by Walkers (Hong Kong).

New Genetron Holding Limited completed the acquisition of Genetron Holdings Limited (NasdaqGM:GTH) on March 28, 2024